Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer by Robin Parihar, Stephen Gottschalk, Ann Leen, Pradip Bajgain, Norihiro Watanabe, Valentina Hoyos, Mary K McKenna, Lauren Kelly, Paul Shafer, Saisha A Nalawade, Arushana Ali, Jarrett Joubert, Juan Fernando Vera Valdes

Get full text